Kiora Pharmaceuticals (KPRX) Treasury Shares (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Treasury Shares came in at $112991.0 in Q1 2026, down 98.47% YoY from $7.4 million in Q1 2025, and down 98.31% on a QoQ basis from $6.7 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Treasury Shares (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of Treasury Shares data on file, last reported at $112991.0 in Q1 2026.
- Quarterly Treasury Shares fell 98.47% year-over-year to $112991.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112991.0 (down 98.47% YoY) and the FY2025 annual result came in at $6.7 million, up 14186.93% from the prior year.
- Treasury Shares slipped to $112991.0 in Q1 2026, from $6.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $13.1 million in Q3 2023 to a low of $46697.0 in Q4 2024.
- A 5-year average of $4.0 million and a median of $1.7 million in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 14186.93% in 2025, down 99.04% in 2025.
- Tracing KPRX's Treasury Shares over 5 years: stood at $177512.0 in 2022, then soared by 717.74% to $1.5 million in 2023, then tumbled by 96.78% to $46697.0 in 2024, then jumped by 14186.93% to $6.7 million in 2025, then tumbled by 98.31% to $112991.0 in 2026.
- The last three Treasury Shares figures came in at $112991.0 (Q1 2026), $6.7 million (Q4 2025), and $71887.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.84 Mn |
| Jun 30, 2026 | 17.84 Mn |
| Mar 31, 2026 | 112,991.00 |
| Mar 31, 2026 | 112,991.00 |
| Dec 31, 2025 | 6.67 Mn |
| Dec 31, 2025 | 6.67 Mn |
| Sep 30, 2025 | 71,887.00 |
| Sep 30, 2025 | 71,887.00 |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Dec 31, 2024 | 46,697.00 |
| Dec 31, 2024 | 46,697.00 |
| Sep 30, 2024 | 7.46 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 7.46 Mn |
| Mar 31, 2024 | 216,788.00 |
| Mar 31, 2024 | 216,788.00 |